Used in pharmaceutical research as a potent and selective agonist for the GPR139 receptor, which is involved in modulating neurotransmitter release in the central nervous system. Investigated for its potential therapeutic effects in neurological and psychiatric disorders, including depression, schizophrenia, and addiction. Shows good blood-brain barrier penetration, making it suitable for central targets. Also employed as a pharmacological tool to study GPR139 receptor function in vitro and in vivo.